alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          OCT-31-2000
<PERIOD-END>                               OCT-31-1999
<CASH>                                            2218
<SECURITIES>                                      3072
<RECEIVABLES>                                     5302
<ALLOWANCES>                                     (100)
<INVENTORY>                                       2890
<CURRENT-ASSETS>                                 13707
<PP&E>                                            6989
<DEPRECIATION>                                  (4525)
<TOTAL-ASSETS>                                   19412
<CURRENT-LIABILITIES>                             2541
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         16871
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                     16871
<SALES>                                          18272
<TOTAL-REVENUES>                                 18272
<CGS>                                             8162
<TOTAL-COSTS>                                    14248
<OTHER-EXPENSES>                                 (115)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               (425)
<INCOME-PRETAX>                                 (3598)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                             (3598)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    (3598)
<EPS-BASIC>                                     (0.67)
<EPS-DILUTED>                                   (0.67)


</TABLE>
Editorial Note on Part 410
Editorial Note: Nomenclature changes to part 410 appear at 62 FR 46037, Aug. 29, 1997.

§ 410.170 Payment for home health services, for medical and other health services furnished by a provider or an approved ESRD facility, and for comprehensive outpatient rehabilitation facility (CORF) services: Conditions. Payment under Medicare Part B, for home health services, for medical and other health services, or for CORF services, may be made to the provider or facility only if the following conditions are met: ( a ) *Request for payment.* A written request for payment is filed by or on behalf of the individual to whom the services were furnished.
( b ) *Physician or allowed practitioner certification.* For home health services, a physician or allowed practitioner provides certification and recertification in accordance with § 424.22 of this chapter.
( c ) In the case of home dialysis support services described in § 410.52, the services are furnished in accordance with a written plan prepared and periodically reviewed by a team that includes the patient's physician and other professionals familiar with the patient's condition as required by § 494.90 of this chapter.
[51 FR 41339, Nov. 14, 1986, as amended at 53 FR 6648, Mar. 2, 1988; 73 FR 20474, Apr. 15, 2008; 85 FR 70354, Nov. 4, 2020]
#### Butty HENN, Appellant, v. Richard S. BANICK, as Administrator of the Estate of Jay M. Lurie, Deceased, Appellee.

No. 74-103.

District Court of Appeal of Florida, Fourth District.

April 26, 1974.

Rehearing Denied May 28, 1974.

PER CURIAM.

Affirmed.
bdco_ex104.htm


EXHIBIT 10.4


 








GEL TEX MARKETING, LLC


 


June 1, 2012


 


ACKNOWLEDGEMENT LETTER


 


 


Lazarus Energy LLC


c/o Lazarus Energy  Holdings LLC


801 Travis, Suite 2100


Houston, Texas  77002


Attention:  Jonathan Carroll


 



	 	
Re:

	Confirmation of amounts owed by Lazarus Energy LLC, a Delaware limited liability company ("Lazarus"), to GEL Tex Marketing, LLC, a Delmvare limited liability company ("GEL"), pursuant to that certain Joint Marketing Agreement, dated as of August12, 2011 (as amended, the "Marketing Agreement"), by and between Lazarus and GEL.





 


Dear Mr. Catroll:



We are providing you with this Acknowledgment Letter in connection with the Marketing Agreement. Capitalized terms used but not defined in this Acknowledgement Letter have the meanings given them in the Marketing Agreement.



The current outstanding  balance as of the date hereof of all monetary obligations owed by Lazarus to GEL pursuant to the Marketing Agreement due to losses sustained by Lazarus during any Deficit Month is as follows (such total amount being the "Deficit Amount"):


 



	
Over Advance amount for the Lazarus Operational Payments:

	 	$	1,008,890.42	 
	 	 	 	 	 
	
Underpayment amount for the Third Party Transpmtation Costs:

	 	$	964,645.72	 
	 	 	 	 	 
	
Underpayment amount for the Tank Storage Fees:

	 	$	314,912.95	 
	 	 	 	 	 
	
Underpayment  amount for the Inspection Payments:

	 	$	54,563.20	 
	 	 	 	 	 
	
Underpayment  amount for the GEL Transportation Costs1:

	 	$	54,280.00	 
	 	 	 	 	 
	
Underpayment  amount to GEL for the Base Construction Payment':

	 	$	3,882.21	 
	 	 	 	 	 
	
Total Aggregate Deficit Amount:

	 	$	2,401,174.50	 
	 	 	 	 	 
	
1 : As of April 30, 2012; subject to change as of May 31. 201 2.


Note: Deficit Amount excludes crude oil and refined product inventories and obligations.

	 	 	 	 





 




  





  











  











June l , 2012


Page 2


 


In accordance with Exhibit B of the Marketing Agreement, GEL shall not remit to Lazarus any payments of the Lazarus Profit Share  until the subsequent  calendar month after the date upon which the profits from the sale of the Nixon Product at the Facility provide for a full payment of the Deficit Amount to GEL as noted on the previous page of th i s Acknowledgement  Letter, or any future Deficit Amount that has not been paid in full.



Lazarus shall hereby deliver to GEL the following requested information prior to any additional monies, incl uding Operational Payments, being remitted to Lazarus by GEL.




 


1.)  Minimum operating expense budget detail


 


2.)  Detailed list of outstanding operating expenses to be paid


 


3.)  Confirmation receipts and records for all sales tax payments remitted by Lazarus to the state and federal government


 


 


[Signature page to follow]


 




  





  











  











Please confim your agreement  with this Acknowledgement  Letter by signing and returning to us a copy of this document. Thank you for your assistance.




 







 


 


 


 


 


 


SIGNATURE PAGE TO ACKNOWLEDGEMENT LETTER
§ 121.1 Applicability. ( a ) The provisions of this part, with the exception of §§ 121.13 and 121.14, apply to the operation of the Organ Procurement and Transplantation Network (OPTN) and the Scientific Registry.
( b ) The provisions of § 121.13 apply to the prohibition set forth in section 301 of the National Organ Transplant Act, as amended.
( c ) The provisions of § 121.14 apply to the reimbursement of specified incidental non-medical expenses incurred toward living organ donation under section 377 of the Public Health Service Act, as amended.
( d ) In accordance with section 1138 of the Social Security Act, hospitals in which organ transplants are performed and which participate in the programs under titles XVIII or XIX of the Social Security Act, and organ procurement organizations designated under section 1138(b) of the Social Security Act, are subject to the requirements of this part.
[85 FR 59444, Sept. 22, 2020]
HomeSaudi Arabia

# Saudi Arabia

369 items

        -    Readout  		Secretary Blinken’s Call with Saudi Foreign Minister Faisal bin Farhan Al Saud	  March 22, 2021 
        -    Department Press Briefing  		Department Press Briefing – March 19, 2021	  Jalina PorterMarch 19, 2021WASHINGTON, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 15, 2021	  Jalina PorterMarch 15, 2021Washington, D.C. 
        -    Media Note  		Joint Statement of the Governments of France, Germany, Italy, the United Kingdom, and the United States of America on Houthi Attacks	  March 11, 2021 
        -    Department Press Briefing  		Department Press Briefing – March 4, 2021	  Ned PriceMarch 4, 2021Washington, D.C. 
        -    Interview  		Secretary Antony J. Blinken with Judy Woodruff of PBS NewsHour	  Antony J. BlinkenMarch 3, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 3, 2021	  Ned PriceMarch 3, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 2, 2021	  Ned PriceMarch 2, 2021Washington, D.C. 
        -    Department Press Briefing  		Department Press Briefing – March 1, 2021	  Ned PriceMarch 1, 2021Washington, D.C.  
        -    Press Statement  		Houthi Attacks on Saudi Arabia	  Ned PriceFebruary 28, 2021 

previous page1…3031323334…37next page

Back to Top
#### STATE of Louisiana ex rel. Thomas McMILLAN v. C. Murray HENDERSON, Warden, Louisiana State Penitentiary.

No. 55305.

Supreme Court of Louisiana.

Sept. 20, 1974.

In re: Thomas McMillan applying for Writ of Mandamus and Habeas Corpus, In-junctive Relief and other Available Remedies.

Writ denied. The application is moot. Action has been taken by applicant’s counsel to fix the hearing on his application in the trial court. Mandamus, therefore, will not lie.
#### § 405.1008 Parties to the proceedings on a request for an ALJ hearing.

The party who filed the request for hearing and all other parties to the reconsideration are parties to the proceedings on a request for an ALJ hearing. In addition, a representative of CMS or its contractor may be a party under the circumstances described in § 405.1012.

[82 FR 5110, Jan. 17, 2017]
Document

Exhibit 10.16

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
Our non-employee directors receive an annual retainer of $45,000. Our lead director receives an additional retainer of $30,000. In addition, all non-employee directors who serve on one or more committees will receive the following annual committee fees: 


																		
	Committee			Chair		Member
	Audit		$	20,000 			$	10,000 	
	Compensation		15,000 			7,500 	
	Nominating and Corporate Governance		10,000 			5,000 	




Other than the annual retainers and committee fees described above, non-employee directors are not entitled to receive any cash fees in connection with their service on our Board. Each non-employee director is granted an equity grant for a fair value of $120,000, consisting of an equal amount of stock options and RSUs, at each annual stockholders’ meeting, provided the non-employee director has served since March 1st of the year the annual meeting was held and continued to serve. The stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and vest monthly over one year from the date of grant. The RSU awards cliff vest 100%, one year from the date of grant. New non-employee directors receive an initial stock option grant for a fair value of $200,000. The initial grants have an exercise price equal to the fair market value of our common stock on the date of grant and vest 25% in one year and monthly thereafter over the next three years, provided the non-employee director continues to serve. All of the Board stock options and RSUs described in this paragraph become fully vested upon a change in control. 
Prior to the beginning of each year, each non-employee director may elect to receive their annual retainer for the following year in the form of a stock option that vests monthly over one year from the beginning of the year. The option is granted at the first Board or Compensation Committee meeting of the year for a fair value equivalent to their annual retainer with an exercise price equal to the fair market value of our common stock on the date of grant. These options are not subject to vesting acceleration upon a change in control. 
We have a policy of reimbursing our directors for their reasonable out-of-pocket expenses in connection with attending Board of Directors and committee meetings.
#### § 561.306 Correspondent account.

The term *correspondent account* means an account established by a U.S. financial institution for a foreign financial institution to receive deposits from, or to make payments on behalf of, the foreign financial institution, or to handle other financial transactions related to such foreign financial institution.
#### § 37.103 Medical examination at miner's expense.

Any miner who wishes to obtain a medical examination at the miner's own expense at an approved spirometry or radiography facility and to have the complete examination submitted to NIOSH may do so, provided that the examination is made no sooner than 6 months after the most recent examination of the miner submitted to NIOSH. NIOSH will provide radiographic classification, evaluation of spirometry test results, and reporting of the results of examinations made at the miner's expense in the same manner as if they were submitted under an operator's plan. Any change in the miner's transfer rights under the Act that may result from this examination will be subject to the terms of § 37.102.

[81 FR 73290, Oct. 24, 2016]
#### § 584.509 Emergency medical services.

The provision and receipt of nonscheduled emergency medical services that are otherwise prohibited by this part or any Executive orders or further Presidential action relating to the Magnitsky Act are authorized.
§ 22.3 Appointment of special consultants. ( a ) When the Public Health Service requires the services of consultants who cannot be obtained when needed through regular Civil Service appointment or under the compensation provisions of the Classification Act of 1949, special consultants to assist and advise in the operations of the Service may be appointed, subject to the provisions of the following paragraphs and in accordance with such instructions as may be issued from time to time by the Secretary of Health and Human Services.
( b ) Appointments, pursuant to the provisions of this section, may be made by those officials of the Service to whom authority has been delegated by the Secretary or his designee.
( c ) The per diem or other rates of compensation shall be fixed by the appointing officer in accordance with criteria established by the Surgeon General.
(Sec. 208(c), 58 Stat. 686, as amended; 42 U.S.C. 209(e); sec. 207(f), 58 Stat. 686 as amended by 62 Stat. 40; 42 U.S.C. 209(f))
[21 FR 9821, Dec. 12, 1956, as amended at 31 FR 12939, Oct. 5, 1966]
HomePoland

# Poland

183 items

        -    TIAS  		Poland (09-301) – Agreement on Social Security	  April 1, 2009 
        -    TIAS  		Poland (08-1113) – Agreement on Cooperation Within the Framework of the Polish-US Fulbright Commission	  November 13, 2008 
        -    TIAS  		Poland (07-1009) – Agreement Concerning Security Measures for the Protection of Classified Information in the Military Sphere	  October 9, 2007 
        -    TIAS  		Poland (07-622.1) – Memorandum of Understanding Regarding Reciprocal Government Quality Assurance Services	  June 22, 2007 
        -    TIAS  		Poland (06-1122) – Agreement for Scientific and Technical Cooperation	  November 22, 2006 
        -    TIAS  		Poland (04-0820) – Additional Protocol to the Treaty Concerning Business and Economic Relations	  August 20, 2004 
        -    TIAS  		Poland (04-209) – Agreement Amending the Annex to the Agreement of November 8, 1976, as Amended, Relating to the Acceptance of Certificates of Airworthiness for Imported Aircraft Products	  February 9, 2004 
        -    TIAS  		Poland (13155) – Air Transport Agreement	  September 15, 2003 
        -    TIAS  		Poland (99-917.1) – Treaty on Mutual Legal Assistance	  September 17, 1999 
        -    TIAS  		Poland (99-917) – Treaty on Extradition	  September 17, 1999 

previous page1…16171819next page

Back to Top
# Turkmenistan

69 items

        -    Report  		Turkmenistan	  May 29, 2018 
        -    Report  		Turkmenistan	  April 20, 2018 
        -    Report  		Turkmenistan	  August 15, 2017 
        -    Report  		Turkmenistan	  June 29, 2017 
        -    Report  		Turkmenistan	  June 27, 2017 
        -    Report  		Turkmenistan	  March 3, 2017 
        -    TIAS  		Turkmenistan (04-130) – Agreement Regarding the Surrender of Persons to the International Criminal Court	  January 30, 2004 
        -    TIAS  		Turkmenistan (13053) – Agreement Relating to the Employment of Dependents of Official Government Employees	  July 20, 1999 
        -    TIAS  		Turkmenistan (99-424) – Defense Assistance Agreement	  April 24, 1999 

previous page1…567

Back to Top
#### § 1003.910 Amount of penalties.

For each individual violation of section 351A(b) or (c) of the Public Health Service Act or 42 CFR part 73, the OIG may impose a penalty of not more than $250,000 in the case of an individual, and not more than $500,000 in the case of any other person.

[81 FR 88362, Dec. 7, 2016, as amended at 88 FR 42841, July 3, 2023]
#### § 136.352 Fair and uniform provision of services.

Contracts with urban Indian organizations under this subdivision shall incorporate the following clause:

The Contractor agrees, consistent with medical need, and the efficient provision of medical services to make no discriminatory distinctions against Indian patients or beneficiaries of this contract which are inconsistent with the fair and uniform provision of services.
#### § 579.508 Emergency medical services.

The provision and receipt of nonscheduled emergency medical services that are otherwise prohibited by this part or any further Executive orders relating to the national emergency declared in Executive Order 13848 of September 12, 2018, are authorized.
Editorial Note on Part 410
Editorial Note: Nomenclature changes to part 410 appear at 62 FR 46037, Aug. 29, 1997.

§ 410.30 Prescription drugs used in immunosuppressive therapy. ( a ) *Scope.* Payment may be made for prescription drugs used in immunosuppressive therapy that have been approved for marketing by the FDA and that meet one of the following conditions: ( 1 ) The approved labeling includes the indication for preventing or treating the rejection of a transplanted organ or tissue.
( 2 ) The approved labeling includes the indication for use in conjunction with immunosuppressive drugs to prevent or treat rejection of a transplanted organ or tissue.
( 3 ) Have been determined by a carrier (in accordance with part 421, subpart C of this chapter), in processing a Medicare claim, to be reasonable and necessary for the specific purpose of preventing or treating the rejection of a patient's transplanted organ or tissue, or for use in conjunction with immunosuppressive drugs for the purpose of preventing or treating the rejection of a patient's transplanted organ or tissue. (In making these determinations, the carriers may consider factors such as authoritative drug compendia, current medical literature, recognized standards of medical practice, and professional medical publications.)
( b ) *Eligibility.* For drugs furnished on or after December 21, 2000, coverage is available only for prescription drugs used in immunosuppressive therapy, furnished to an individual who received an organ or tissue transplant for which Medicare payment is made, provided the individual is eligible to receive Medicare Part B benefits, including, beginning January 1, 2023, an individual who meets the requirements specified in § 407.55 of this subchapter.
( c ) *Coverage.* Drugs are covered under this provision irrespective of whether they can be self-administered.
[60 FR 8955, Feb. 16, 1995. Redesignated at 63 FR 34327, June 24, 1998; 74 FR 62002, Nov. 25, 2009; 87 FR 66510, Nov. 3, 2022]
# C_2005330EN.01002302.xml

| 24.12.2005 | EN | Official Journal of the European Union | C 330/23 |
| --- | --- | --- | --- |

24.12.2005

EN

Official Journal of the European Union

C 330/23

---

Action brought on 26 September 2005 — Anheuser-Busch/OHIM

(Case T-366/05)

(2005/C 330/57)

Language in which the application was lodged: English

Parties

Applicant(s): Anheuser-Busch, Inc. (St. Louis, USA) [represented by: V. von Bomhard, A. Renck, A. Pohlmann, G. Burkhart, lawyers]

Applicant(s):

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Defendant

Other party/parties to the proceedings before the Board of Appeal: Budějovický Budvar, národní podnik (České Budějovice, Czech Republic)

Other party/parties to the proceedings before the Board of Appeal:

Form of order sought

| — | Partially annul the decision of the Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 11 July 2005 (Case R 514/2004-2), namely insofar as the application was rejected for goods in class 33, and |
| --- | --- |

—

Partially annul the decision of the Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 11 July 2005 (Case R 514/2004-2), namely insofar as the application was rejected for goods in class 33, and

| — | Order that the costs of the proceedings be borne by the defendant. |
| --- | --- |

—

Order that the costs of the proceedings be borne by the defendant.

Pleas in law and main arguments

Applicant for the Community trade mark: The applicant

Applicant for the Community trade mark:

Community trade mark concerned: The word mark ‘BUDWEISER’ for goods in classes 32 and 33 — application No 1 603 489

Community trade mark concerned:

Proprietor of the mark or sign cited in the opposition proceedings: Budějovický Budvar, národní podnik

Proprietor of the mark or sign cited in the opposition proceedings:

Mark or sign cited: The international figurative marks and word mark ‘BUDWEISER’ and ‘BUDWEISER BUDVAR’ for goods in classes 31 and 32

Mark or sign cited:

Decision of the Opposition Division: Opposition upheld for all the contested goods

Decision of the Opposition Division:

Decision of the Board of Appeal: Dismissal of the appeal

Decision of the Board of Appeal:

Pleas in law: Infringement of Article 8(1)(b) of Council Regulation No 40/94 as there is no likelihood of confusion between the conflicting marks. The goods are sufficiently dissimilar to exclude any confusion on the part of the consumer.

Pleas in law:

---
# Portugal

67 items

        -    Media Note  		Assistant Secretary of State Satterfield Travels to Portugal	  February 26, 2024 
        -    Special Needs Profile  		Lisbon, Portugal: Carlucci American International School of Lisbon: 2024 Special Needs Profile	  February 22, 2024 
        -    Media Note  		Partnership for Atlantic Cooperation Senior Officials Meeting	  February 20, 2024 
        -    Overseas Schools Fact Sheet  		Lisbon, Portugal: Carlucci American International School of Lisbon: 2023-2024 Fact Sheet	  October 18, 2023 
        -    Report  		2023 Investment Climate Statements: 	  July 26, 2023 
        -    Media Note  		Senior Coordinator for Atlantic Cooperation Lapenn’s Travel to Portugal and Belgium	  July 14, 2023 
        -    Report  		2023 Trafficking in Persons Report: Portugal	  June 15, 2023 
        -    Press Statement  		The Day of Portugal, Camões, and the Portuguese Communities	  Antony J. BlinkenJune 12, 2023 
        -    Report  		2022 Report on International Religious Freedom: Portugal	  May 15, 2023 
        -    Media Note  		U.S. Department of State Announces 2,100 Benjamin Gilman Scholars, Expanding Access to Study Abroad for American Undergraduate Students	  May 10, 2023 

123…7next page

Back to Top
###### Editorial Note on Subpart C of Part 405

#### Editorial Note:

Nomenclature changes to subpart C of part 405 appear at 76 FR 5961, Feb. 2, 2011.

#### § 405.354 Procedures for adjustment or recovery—title II beneficiary.

The procedures applied in making an adjustment or recovery in the case of a title II beneficiary are the applicable procedures of 20 CFR 404.502.

[31 FR 13534, Oct. 20, 1966, as amended at 32 FR 18027, Dec. 16, 1967. Redesignated at 42 FR 52826, Sept. 30, 1977]